Introduction
Designing vape packaging is not simply a branding exercise. In the United States, nicotine-containing vape products and other covered tobacco products are subject to specific federal labeling requirements. A package can look polished and professional yet still create compliance problems if its warning statement is too small, poorly positioned, or difficult to read.
For brands, manufacturers, importers, and packaging designers, understanding vape warning label design rules for 2025 is essential before approving artwork for production. The FDA requires covered tobacco product packages to display a prescribed nicotine warning and sets rules covering its location, size, typography, contrast, and presentation.
This guide explains the main U.S. federal requirements and the practical design considerations businesses should understand before sending vape packaging to print.
What Are the Vape Warning Label Design Rules for 2025?
The core federal rule for covered tobacco products, including many e-cigarettes, e-liquids, and electronic nicotine delivery systems, requires the package to display the following warning:
“WARNING: This product contains nicotine. Nicotine is an addictive chemical.”
The warning must be presented on the package according to specific formatting requirements. FDA states that covered tobacco product packages must display the warning on the two principal display panels and that it must occupy at least 30 percent of each panel.
These requirements are not new for 2025. The compliance date for the applicable warning requirement was August 10, 2018. However, the requirements remain important when designing or updating vape packaging in 2025.
Businesses should therefore avoid treating the warning as a small piece of copy that can simply be added after the main artwork has been completed. It needs to be incorporated into the packaging layout from the beginning.
FDA Warning Text for Vape Packaging
The exact wording matters.
For covered tobacco products containing nicotine, the required federal warning is:
“WARNING: This product contains nicotine. Nicotine is an addictive chemical.”
The capitalization and punctuation are part of the prescribed wording. FDA specifically states that the warning must be capitalized and punctuated as indicated in the regulation.
Changing the wording into a marketing-friendly alternative can create compliance concerns. For example, a designer should not replace the required statement with a shortened phrase such as “Contains nicotine” simply because it fits the package better.
The safest approach is to place the required regulatory wording into the artwork exactly as required and design the rest of the package around it.
For a broader regulatory reference, businesses can review the FDA’s FDA labeling and warning statement rules.
Where Should the Vape Warning Appear?
Placement is one of the most important parts of vape warning label design rules for 2025.
The FDA requires the warning to appear in a conspicuous and prominent location on the two principal display panels of the package. It must occupy at least 30 percent of each principal display panel.
This means the warning cannot simply be moved to a small side panel because the front of the package has already been filled with branding.
Packaging designers should identify the principal display panels before creating the final artwork. On many rectangular boxes, these will be the two largest surfaces consumers see, but packaging structures can vary.
The warning must also appear directly on the package and remain clearly visible underneath any clear wrapping or cellophane.
This is particularly relevant when packaging includes transparent films, protective sleeves, or other outer materials.
The 30 Percent Rule for Vape Warnings
The 30 percent requirement is a major design consideration.
Under the federal rule, the required warning must comprise at least 30 percent of each of the two principal display panels.
Design teams should calculate this requirement against the actual package structure rather than assuming that a warning block looks large enough visually.
For example, if a package has a large front panel, a warning that appears prominent to a designer may still fail the required proportional measurement.
The warning area should therefore be established during the initial packaging design stage. This prevents the common problem of finishing the entire package design and discovering that there is insufficient room for the legally required warning.
Font and Typography Requirements
Typography is another important part of vape warning label design rules for 2025.
FDA requires the warning to be printed in at least 12-point font size. The warning should occupy the greatest possible proportion of the warning area set aside for the required text.
The required warning must also use a conspicuous and legible sans-serif typeface. FDA identifies Helvetica bold and Arial bold as examples of acceptable typography, along with other similar sans-serif fonts.
This creates a practical distinction between the warning and the brand’s creative typography.
A vape brand might use a custom typeface for its logo or product name, but the legally required warning should not be treated as another branding element. The warning needs to remain highly legible and visually distinct.
Designers should also avoid unnecessarily reducing the warning font simply to preserve additional space for product imagery or promotional messaging.
Black-and-White Contrast Requirements
Contrast is essential for readability.
FDA specifies that the warning should be presented using black text on a white background or white text on a black background. The warning must contrast with other printed material through typography, layout, or color.
This means a designer should avoid placing the warning over a photograph, gradient, colorful illustration, or complicated background.
Even if the words technically appear on the package, poor contrast can make the warning difficult to read. A clean, high-contrast warning block is therefore both a regulatory consideration and a sensible design practice.
The warning should also be visually separated from decorative elements that could compete with the text.
Centering and Orientation of the Warning
The FDA rules also address how the warning is positioned inside its designated area.
The required warning must be centered within the warning area. Its orientation must also match the orientation of the other information appearing on the principal display panel.
This is easy to overlook when working with unusual package shapes.
For example, rotating the warning to fit a narrow side area is not an appropriate solution if that panel is not one of the required principal display panels. Similarly, designers should avoid turning the warning vertically merely to create more room for branding.
The warning should be planned as a fixed component of the package architecture rather than an element that is moved around during the final design stage.
What About Small Vape Packages?
Small packaging creates a particular challenge because the required warning still needs to remain legible and meet the applicable design specifications.
FDA provides an alternative approach for covered tobacco products that are too small or otherwise unable to accommodate the required warning directly on the package. In those circumstances, the warning can appear on a carton, outer container, wrapper, or a tag that is firmly and permanently attached to the tobacco product package.
This provision can be important for compact vape products, small containers, and other packaging formats where surface area is limited.
However, businesses should not automatically assume that a small package eliminates the warning requirement. Instead, the applicable alternative packaging method should be evaluated carefully.
Does a Zero-Nicotine Vape Need the Same Warning?
The answer depends on how the product is classified.
FDA explains that a tobacco product made or derived from tobacco that does not contain nicotine may use an alternative statement if the manufacturer submits the required confirmation to FDA and has supporting data demonstrating the absence of nicotine. The alternative statement is:
“This product is made from tobacco.”
Products that contain neither tobacco nor nicotine and are not made or derived from tobacco or nicotine may fall outside the definition of a covered tobacco product for purposes of this particular warning requirement.
Therefore, simply describing a product as “zero nicotine” should not automatically lead a designer to remove regulatory warnings. Product classification and supporting documentation matter.
Other Information Required on Vape Packaging
The nicotine warning is only one part of the broader labeling framework.
FDA notes that tobacco products subject to its authority may also need information such as the name and place of business of the manufacturer, packer, or distributor and an accurate statement of the quantity of contents. FDA also identifies the required “Sale only allowed in the United States” statement for applicable products.
The exact requirements can depend on the product, its classification, packaging format, and other applicable regulations.
This is why packaging teams should not treat the nicotine warning as the entire compliance review.
Importers should also pay close attention to labeling because FDA states that it examines tobacco product labels at importation and reviews issues including general labeling requirements and nicotine warnings.
Vape Advertising and Warning Statements
Packaging is not the only area where warning requirements can matter.
Federal regulations also address warning statements in advertising for covered tobacco products. FDA has stated that advertising for covered tobacco products, including applicable ENDS products, must bear the required nicotine warning and comply with the relevant formatting requirements.
This matters when a brand uses the same artwork across product boxes, websites, digital advertisements, retail displays, and social media.
A package design that complies with the packaging rules should not automatically be copied into every advertising environment without checking the requirements that apply to that particular medium.
Common Vape Warning Label Design Mistakes
One frequent mistake is making the warning too small because the designer prioritizes the logo, product name, or flavor artwork.
Another problem occurs when the warning is placed on only one prominent panel instead of both required principal display panels.
Poor contrast is another concern. Warning text printed over colorful illustrations or complex backgrounds can become difficult to read.
Designers may also use a decorative font that does not provide the required legibility. FDA specifically identifies Helvetica bold and Arial bold as examples of appropriate sans-serif typography.
Finally, businesses sometimes approve packaging without checking the finished physical product. A digital proof can look correct while folds, seams, wrapping, or structural changes affect how the warning appears on the final package.
How to Build Compliance Into the Design Process
A better approach is to establish the warning area before creative development begins.
Start by identifying the two principal display panels. Then reserve at least the required 30 percent of each panel for the warning. Establish the appropriate font, contrast, capitalization, punctuation, orientation, and alignment before adding the rest of the artwork.
The physical prototype should then be reviewed before mass production.
This approach reduces the risk of discovering a compliance problem after thousands of packages have already been printed.
Businesses should also keep documentation showing which regulatory requirements were reviewed and who approved the final artwork. For regulated products, maintaining a clear review process can be just as valuable as producing attractive packaging.
How Vape Taxes Can Affect Packaging and Pricing Decisions
Packaging compliance and pricing strategy are separate issues, but they often intersect during product planning.
Different jurisdictions can impose different vape taxes, which can affect retail prices and the commercial presentation of products. Brands selling across multiple markets should therefore evaluate regulatory requirements alongside their pricing and distribution strategy.
For additional context, see Vape Taxes and Regional Price Differences.
Understanding the tax environment can help businesses plan packaging quantities, product variants, and market-specific distribution without confusing pricing requirements with federal warning-label obligations.
Why Regulatory Review Should Happen Before Printing
Correcting packaging after production can be expensive.
If a warning is incorrectly sized or positioned, a company may need to modify artwork, reorder packaging materials, delay distribution, or deal with additional compliance questions.
The most efficient point to identify these problems is before the artwork reaches the printer.
A practical review should therefore examine the exact wording, panel placement, 30 percent coverage, font size, font style, contrast, orientation, and visibility of the warning. It should also consider other applicable labeling requirements and state-specific rules.
FDA’s official guidance remains the appropriate starting point because requirements can change and different tobacco product categories can be subject to different rules.
Get Vape Warning Label Design Right
The key to successful vape warning label design rules for 2025 is to treat regulatory requirements as part of the design brief rather than as an afterthought.
For applicable U.S. covered tobacco products, the FDA-required nicotine warning must use the prescribed wording and meet requirements for placement, size, typography, contrast, centering, and orientation. The warning must occupy at least 30 percent of each of the two principal display panels.
Brands should verify the complete labeling framework before printing and should remember that state and local requirements may impose additional obligations.
If you are developing or updating vape packaging, review the applicable FDA requirements first, build the warning area into your artwork from the beginning, and have the final physical package checked before approving a large print run. For further industry information and related vaping topics, visit vapexplore.
FAQs
What warning must be on vape packaging?
For applicable U.S. covered tobacco products containing nicotine, the required warning is: “WARNING: This product contains nicotine. Nicotine is an addictive chemical.” FDA also specifies requirements for its size, placement, typography, and presentation.
How big does a vape warning label have to be?
For covered tobacco product packaging, the warning must comprise at least 30 percent of each of the two principal display panels.
What font is required for FDA vape warning labels?
FDA requires the warning to be printed in at least 12-point type and specifies conspicuous, legible sans-serif typography. Helvetica bold and Arial bold are identified as examples.
Do vape products have to have warning labels?
Applicable covered tobacco products must carry the required warning on their packaging, and applicable advertising must also display the required warning. FDA identifies electronic nicotine delivery systems among the products covered by its labeling and warning framework.
Does a zero-nicotine vape need a nicotine warning?
Not necessarily. FDA provides an alternative warning for certain tobacco products made or derived from tobacco that do not contain nicotine, provided the manufacturer follows the required self-certification process. Products that are neither tobacco nor nicotine products and are not made or derived from either may fall outside this particular warning requirement.
Can the FDA vape warning label be placed on the back only?
For applicable covered tobacco products, the warning must appear on both principal display panels and occupy at least 30 percent of each panel. Therefore, placing it only on the back does not satisfy the federal packaging requirement.
